logo, Nilogen Oncosystems

A Fresh Approach
to Immuno-Oncology

Bringing the complex tumor microenvironment to life with 3D ex vivo assays

Cancer. Up close and personal.

One of drug development’s biggest challenges is that cell lines and animal models cannot capture the full complexity of the tumor microenvironment. But we take an innovative approach by analyzing fresh patient tumor tissue that remains embedded in its natural environment.

With our proprietary 3D ex vivo drug screening platforms, you can reveal characteristics of the tumor microenvironment to accurately assess the therapeutic potential of drug treatments, including immunotherapies.